Newly Approved Agents in HER2-Positive Metastatic Breast Cancer with Dr Mark Pegram

Episode 58 · March 3rd, 2021 · 1 hr 5 mins

About this Episode

Dr Mark Pegram from the Stanford University School of Medicine discusses the latest clinical data on and optimal use of newly approved therapies for HER2-positive metastatic breast cancer.

CME information and select publications here.